Issues in clinical trial design I: Use of natural history controls. An antagonist view

Lack of association of VEGF promoter polymorphisms with sporadic ALS.

Neurology·2006

Paraoxonase cluster polymorphisms are associated with sporadic ALS.

Neurology·2006

Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.

Neurology·1996

Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans.

Cancer·1994

Glycemic control and peripheral nerve conduction in children and young adults after 5-6 mo of IDDM. Wisconsin Diabetes Registry.

Diabetes care·1992

Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium.

Neuromuscular disorders : NMD·1992

Diagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.

Neurology·2026

Diagnostic Yield and Therapeutic Impact of Etiologic Investigations After Status Epilepticus: Insights From the ICTAL Registry.

Neurology·2026

Diagnosis, Treatment, and Prognosis of Cerebral Venous Thrombosis.

Neurology·2026

Vascular Imaging Features and Time-Specific Recurrence Risk After Craniocervical Artery Dissection.

Neurology·2026

Neuroradiologic Findings in Patients With SCN2A Disease: A Systematic Review and Retrospective Multicenter Cohort Study.

Neurology·2026

Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis.

Neurology·2026

Epigenetic control of cellular plasticity in breast cancer progression.

The FEBS journal·2026

Three-Dimensional Collagen Microenvironment Activates NF-κB/Stat3 Axis to Promote Cancer Chemoresistance and Partial EMT in Head and Neck Squamous Cell Carcinoma.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Tumor-nerve crosstalk: peripheral mechanisms mediating bone tumor progression and cancer-induced bone pain.

Frontiers in oncology·2026

Tertiary lymphoid structures in urothelial carcinoma: bridging spatial architecture with therapeutic vulnerability in the post-BCG era.

Frontiers in immunology·2026

Related Experiment Videos

Issues in clinical trial design I: Use of natural history controls. An antagonist view

Related Concept Videos

Lack of association of VEGF promoter polymorphisms with sporadic ALS.

Paraoxonase cluster polymorphisms are associated with sporadic ALS.

Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.

Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans.

Glycemic control and peripheral nerve conduction in children and young adults after 5-6 mo of IDDM. Wisconsin Diabetes Registry.

Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium.

Diagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.

Diagnostic Yield and Therapeutic Impact of Etiologic Investigations After Status Epilepticus: Insights From the ICTAL Registry.

Diagnosis, Treatment, and Prognosis of Cerebral Venous Thrombosis.

Vascular Imaging Features and Time-Specific Recurrence Risk After Craniocervical Artery Dissection.

Neuroradiologic Findings in Patients With SCN2A Disease: A Systematic Review and Retrospective Multicenter Cohort Study.

Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis.

Epigenetic control of cellular plasticity in breast cancer progression.

Three-Dimensional Collagen Microenvironment Activates NF-κB/Stat3 Axis to Promote Cancer Chemoresistance and Partial EMT in Head and Neck Squamous Cell Carcinoma.

Tumor-nerve crosstalk: peripheral mechanisms mediating bone tumor progression and cancer-induced bone pain.

Tertiary lymphoid structures in urothelial carcinoma: bridging spatial architecture with therapeutic vulnerability in the post-BCG era.

Related Experiment Videos

Issues in clinical trial design I: Use of natural history controls. An antagonist view

Related Concept Videos

Related Articles